VYGR ▼ -3.4% - Voyager Therapeutics, Inc. $VYGR - Voyager’s Tau-Targeted Gene Therapy VY1706 and Anti-Tau Antibody VY7523 for Alzheimer’s Disease to Be Featured in Poster Presentations at CTAD 2026 27-OCT-2026 08:01 AM ET